A Different View on Bone Marrow Stem Cells
HSCI Principal Faculty member Les E. Silberstein, MD, details how new imaging technologies allowed his laboratory to discover that bone marrow stem cells are located near blood vessels, but...

By: harvardstemcell

Read this article:
A Different View on Bone Marrow Stem Cells - Video

Stem Cell Therapy for Hair Loss | Hair Loss Treatment in India
Stem Cell Therapy for Hair Loss - Enhances hair regrowth within 2-3 weeks after treatment!

By: AllHairSolution

Originally posted here:
Stem Cell Therapy for Hair Loss | Hair Loss Treatment in India - Video

Newswise LOS ANGELES May 30, 2013 Newport Beach-based nonprofit Coalition Duchenne has awarded a $150,000 grant to a Cedars-Sinai Heart Institute team investigating whether an experimental cardiac stem cell treatment could be used to treat Duchenne muscular dystrophy patients who have developed heart disease.

Coalition Duchenne is led by Catherine Jayasuriya, a mother whose 20-year-old son, Dusty Brandom, has cardiomyopathy associated with Duchenne muscular dystrophy. She was inspired to underwrite cardiac stem cell research at Cedars-Sinai after reading about a successful clinical trial led by Eduardo Marbn, MD, PhD, director of the Cedars-Sinai Heart Institute and the Mark S. Siegel Family Professor.

The experimental stem cell therapy, developed by Marbn, is the only treatment shown in clinical trials to regenerate healthy heart muscle. In the clinical trial, patients underwent biopsies during which doctors removed a piece of heart muscle about the size of half a raisin. The heart tissue was then used to grow specialized heart stem cells, which then were injected back into the patients heart. Results published in The Lancet showed that patients experienced an average 50 percent reduction in muscle damaged by heart attack.

I immediately sensed the potential for applying this rapidly evolving treatment to Duchenne, said Jayasuriya. I made it my personal quest to help get this kind of therapy for Duchenne patients.

Jayasuriyas commitment was further cemented when she discovered that Ron Victor, MD, associate director of the Cedars-Sinai Heart Institute, has been working with Duchenne patients as part of his investigation of the cardiac benefits of sildenafil (Viagra) and tadalafil (Cialis).

We know that boys with Duchenne are born with a small scar in the base of their heart, said Victor, the Burns and Allen Chair in Cardiology Research at the Cedars-Sinai Heart Institute. The damage to hearts in boys with Duchenne increases over time. If we can use stem cells to slow or stop heart damage, it could help stall progression of the disease.

The first step in the study is to examine the effect of injecting cardiac stem cells into the hearts of mice with Duchenne. If the data is positive, the experimental treatment could be rapidly approved for use in humans with Duchenne because of cardiac stem cell treatments have been approved for other patient populations, including those with advanced heart disease.

Each year, 20,000 boys are born with Duchenne, Jayasuriya said, who founded Coalition Duchenne in 2010 to raise global awareness for Duchenne muscular dystrophy, fund research and find a cure for Duchenne. Many do not live into their 20s and we lose many to cardiac issues. We need to focus on changing the course of the disease. We hope that working with cardiac stem cells is one way we will eventually change that outcome.

Duchenne muscular dystrophy is a progressive muscle-wasting disease and the most common fatal disease that affects children. Duchenne occurs in one in 3,500 male births, across all races, cultures and countries. Duchenne is caused by a defect in the gene that produces the protein dystrophin, which helps connect the muscle fiber to the cell membranes. Without dystrophin, muscle cells become unstable, are weakened and lose their functionality. Life expectancy of boys and young men with Duchenne ranges from the mid-teens to the mid-20s. Their minds are unaffected.

The Cedars-Sinai Heart Institute is internationally recognized for outstanding heart care built on decades of innovation and leading-edge research. From cardiac imaging and advanced diagnostics to surgical repair of complex heart problems to the training of the heart specialists of tomorrow and research that is deepening medical knowledge and practice, the Cedars-Sinai Heart Institute is known around the world for excellence and innovations.

Read more:
Grant Funds Research Into Cardiac Stem Cells as Treatment for Heart Disease Related to Duchenne Muscular Dystrophy

The Caring Vet Dr. Michel Selmer: Stem Cell Therapy
By Video Journalist Waldo Cabrera The Caring Vet Dr. Michel Selmer shows how stem cell therapy works. Featured Inte

Link:
The Caring Vet Dr. Michel Selmer: Stem Cell Therapy - Video

Importance of stem cell therapy

By: StemCellVN

Originally posted here:
Importance of stem cell therapy - Video

THE Davao Adventist Hospital is now offering services for autologous stem cell therapy.

Marketing officer Kim Endrei Go said the therapy is the first in Davao City and an alternative treatment for degenerative diseases of joints and bones caused by sports injuries and chronic pains.

Go said the treatment allows the patient to continue the normal routine even after the treatment. He said the therapy is non-surgical and has a healing period of only three days.

The modalities in extracting stem cells in the therapy are either through the Platelet Rich Plasma (PRP) and through Bone Marrow Aspiration Concentrate.

Go said autologous means that the stem cells will be extracted from the patient himself and will be regenerated through an equipment.

The hospital uses the Harvest technologies from the United States which introduced the SmartPrePtm2.

SmartPrePtm2 is used to redefine platelet concentrate systems. Its latest innovation will further expand and enhance the use of autologous bioactive proteins as well as help optimize the condition for healing.

Go said that the therapy session depends on the severeness of the patient's condition. He added that most patients had 3 sessions but some had once or twice.

He said the technology was first practice in their Cebu branch and is now adopted for Davao. He said that in Cebu there about almost 90 treatments since November last where it was launched.

Each session costs P80,000 where about 60 cc of platelet and stem cells will be collected from the patient.

Originally posted here:
Adventist Hospital offers stem cell therapy

Stem Cell Therapy Treatment for Myotonic Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Myotonic Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy...

By: NeuroGen Brain And Spine Institute

The rest is here:
Stem Cell Therapy Treatment for Myotonic Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Treatment for Becker Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Improvement seen after Stem Cell Therapy Treatment for Becker Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. Stem Cell Therapy done at Dr Alok Sharma N...

By: NeuroGen Brain And Spine Institute

Go here to read the rest:
Stem Cell Therapy Treatment for Becker Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video

Brodie Before After Stemlogix Stem Cell Therapy
Brodie a 3 year old rottweiler had a complete cranial cruciate ligament tear of his left rear leg. Dr. Stephanie Meyer at the Creatures Great Small Vet Hos...

By: Stemlogix LLC #39;s Channel

View post:
Brodie Before

VetRegen stem cell therapy.
Please watch this Video though in Polish most is visual. I took out the longer news cast that was Filmed Live in Warsaw My wife Joanna was asked too be on a ...

By: stephen sanford

Original post:
VetRegen stem cell therapy. - Video

Stem Cell Therapy A New Investigational Approach To Arthritis Relief
http://www.innovationsstemcellcenter.com 214.699.6948.

By: InnovationsStemCell

Read more:
Stem Cell Therapy A New Investigational Approach To Arthritis Relief - Video

May 27 2013

Five stroke victims have shown small signs of recovery following pioneering stem cell therapy.

Prof Keith Muir, of Glasgow University, said the results were "not what we would have expected" from the group of patients who had previously shown no indications of their conditions improving.

The trial involved injecting stem cells directly into the damaged parts of the patients' brains, with the hope that they would turn into healthy tissue or "kick-start" the body's own repair processes.

Frank Marsh, 80, one of the nine patients taking part in the trial at Glasgow's Southern General Hospital, told the BBC he had seen improvements in the use of his left hand.

"I can grip certain things that I never gripped before, like the hand rail at the baths, with my left hand as well as my right," he said."It still feels fairly weak and it's still a wee bit difficult to co-ordinate, but it's much better than it was." He added: "I'd like to get back to playing my piano."

His wife Claire said: "He had reached a plateau and wasn't really improving (after his stroke). But following the operation he is able to do things he couldn't do before, such as make coffee, dressing and holding on to things."

The study involved patients who suffered strokes some time ago and had shown no signs of making any further spontaneous improvement.

Prof Muir said the results were "at the present time not what we would have expected in this group but far from being able to say whether it's something specifically related to the cells".

He told BBC Radio 4's Today programme: "We know that some of the cells will survive and potentially turn into relevant tissue. We also suspect that a large part of what we do is kick-starting repair processes that are already present in the body. So there's probably a mixture of things going on. Quite what it is that's happening in the patients, we won't know for some time to come."

Continued here:
UK & World News: Stem cell therapy 'shows results'

Five stroke victims have shown small signs of recovery following pioneering stem cell therapy.

Prof Keith Muir, of Glasgow University, said the results were "not what we would have expected" from the group of patients who had previously shown no indications of their conditions improving.

The trial involved injecting stem cells directly into the damaged parts of the patients' brains, with the hope that they would turn into healthy tissue or "kick-start" the body's own repair processes.

Frank Marsh, 80, one of the nine patients taking part in the trial at Glasgow's Southern General Hospital, told the BBC he had seen improvements in the use of his left hand.

"I can grip certain things that I never gripped before, like the hand rail at the baths, with my left hand as well as my right," he said."It still feels fairly weak and it's still a wee bit difficult to co-ordinate but it's much better than it was."He added: "I'd like to get back to playing my piano."

His wife Claire said: "He had reached a plateau and wasn't really improving (after his stroke). But following the operation he is able to do things he couldn't do before, such as make coffee, dressing, and holding on to things."

The study involved patients who suffered strokes some time ago and had shown no signs of making any further spontaneous improvement.

Prof Muir said the results were "at the present time not what we would have expected in this group but far from being able to say whether it's something specifically related to the cells".

He told BBC Radio 4's Today programme: "We know that some of the cells will survive and potentially turn into relevant tissue. We also suspect that a large part of what we do is kick-starting repair processes that are already present in the body.

"So there's probably a mixture of things going on. Quite what it is that's happening in the patients, we won't know for some time to come."

Link:
Stroke victims show signs of recovery following pioneering stem cell therapy

May 27 2013

Five stroke victims have shown small signs of recovery following pioneering stem cell therapy.

Prof Keith Muir, of Glasgow University, said the results were "not what we would have expected" from the group of patients who had previously shown no indications of their conditions improving.

The trial involved injecting stem cells directly into the damaged parts of the patients' brains, with the hope that they would turn into healthy tissue or "kick-start" the body's own repair processes.

Frank Marsh, 80, one of the nine patients taking part in the trial at Glasgow's Southern General Hospital, told the BBC he had seen improvements in the use of his left hand.

"I can grip certain things that I never gripped before, like the hand rail at the baths, with my left hand as well as my right," he said."It still feels fairly weak and it's still a wee bit difficult to co-ordinate, but it's much better than it was." He added: "I'd like to get back to playing my piano."

His wife Claire said: "He had reached a plateau and wasn't really improving (after his stroke). But following the operation he is able to do things he couldn't do before, such as make coffee, dressing and holding on to things."

The study involved patients who suffered strokes some time ago and had shown no signs of making any further spontaneous improvement.

Prof Muir said the results were "at the present time not what we would have expected in this group but far from being able to say whether it's something specifically related to the cells".

He told BBC Radio 4's Today programme: "We know that some of the cells will survive and potentially turn into relevant tissue. We also suspect that a large part of what we do is kick-starting repair processes that are already present in the body. So there's probably a mixture of things going on. Quite what it is that's happening in the patients, we won't know for some time to come."

See the original post:
Scottish News: Stem cell therapy 'shows results'

Five stroke victims have shown small signs of recovery following pioneering stem cell therapy.

Prof Keith Muir, of Glasgow University, said the results were "not what we would have expected" from the group of patients who had previously shown no indications of their conditions improving.

The trial involved injecting stem cells directly into the damaged parts of the patients' brains, with the hope that they would turn into healthy tissue or "kick-start" the body's own repair processes.

Frank Marsh, 80, one of the nine patients taking part in the trial at Glasgow's Southern General Hospital, told the BBC he had seen improvements in the use of his left hand.

"I can grip certain things that I never gripped before, like the hand rail at the baths, with my left hand as well as my right," he said."It still feels fairly weak and it's still a wee bit difficult to co-ordinate, but it's much better than it was." He added: "I'd like to get back to playing my piano."

His wife Claire said: "He had reached a plateau and wasn't really improving (after his stroke). But following the operation he is able to do things he couldn't do before, such as make coffee, dressing and holding on to things."

The study involved patients who suffered strokes some time ago and had shown no signs of making any further spontaneous improvement.

Prof Muir said the results were "at the present time not what we would have expected in this group but far from being able to say whether it's something specifically related to the cells".

He told BBC Radio 4's Today programme: "We know that some of the cells will survive and potentially turn into relevant tissue. We also suspect that a large part of what we do is kick-starting repair processes that are already present in the body. So there's probably a mixture of things going on. Quite what it is that's happening in the patients, we won't know for some time to come."

The stem cells were created 10 years ago from one sample of nerve tissue taken from a foetus.

Here is the original post:
Stem cell therapy 'shows results'

Biofortified Blog

Gorillas And The Future of Crop Biotechnology Biofortified Blog There are some really cool improvements coming along in several crops that have been developed using the tools of biotechnology – GMOs if you will. Some of these innovations have consumer health benefits. Some expand ways to encourage greater ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEroy1FMU1dFrRpUzcdC_xcOr-1Ew&url=http://www.biofortified.org/2013/05/gorillas-and-the-future-of-crop-biotechnology/

Cizzle Biotechnology Telegraph.co.uk Does the secret to early detection of lung cancer lie in a research lab in York? A small yet innovative start up biotechnology company believes its groundbreaking blood test could lead to early diagnosis and help improve treatment outcomes for lung ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH904OSW4Rwzkw3Pgo3RkgAX0t1iQ&url=http://www.telegraph.co.uk/finance/businessclub/business-club-video/technology-sector-videos/10071683/cizzle-biotechnology.html

Frontiers launches new open-access journal in Bioengineering and Biotechnology EurekAlert (press release) Frontiers, one of the world's largest and fastest growing open-access publishers, announces the launch of a new journal, Frontiers in Bioengineering and Biotechnology. A broad scope journal covering all specialties, Frontiers in Bioengineering and ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE1xhL67unPsnSIH0f2w1Oa-5vyCg&url=http://www.eurekalert.org/pub_releases/2013-05/f-fln052313.php

Generex Biotechnology Corporation (OTCMKTS:GNBT) down by 14.51%, Excel ... GSPInsider Miami, FL 05/24/2013 (GDPInsider) – Generex Biotechnology Corporation (OTCMKTS:GNBT) is trading down by about 14.51% to trade at $0.0330, with a volume of about 10.34 million shares. The introductory price for the stock for the day is $0.04 as ... Active Morning Movers - Northumberland Resources Inc (OTCMKTS:NHUR ...SBWire (press release) Nano Cap Stocks In Focus – Venaxis Inc(NASDAQ:APPY), Generex ...Techsonian (press release) all 7 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHjjvi3TumFLjoqRR_FlNatYzXOxg&url=http://gdpinsider.com/generex-biotechnology-corporation-otcmktsgnbt-down-by-14-51-excel-maritime-carriers-ltd-nyseexm-1905.html

Biotechnology ETF Investing 101 - ETF News And Commentary NASDAQ With ever-increasing health care spending and insatiable demand for new drugs, the biotechnology sector looks poised for good growth going forward. Furthermore, the U.S. biotech sector represents an attractive investment opportunity thanks to increased ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFri8Bl4jsg_JFx_mhj-79ot_p0sA&url=http://www.nasdaq.com/article/biotechnology-etf-investing-101-etf-news-and-commentary-cm247227